Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone in mild to moderate COVID-19 pneumonia
IRCT20151227025726N17Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Apr 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of dexamethasone in coronavirus pneumonia (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Need for mechanical ventilation and Death. Started Apr 2020; status: completed.
02
Drugs
dexamethasone
03
Conditions
coronavirus pneumonia
Beyond the preview
Go deeper on IRCT20151227025726N17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20151227025726N17.